The expression of mRNA for elafin/SKALP, an inhibitor of leukocyte elastase and proteinase 3, in human normal and psoriatic epidermis was examined by in situ hybridization. In normal epidermis, elafin/SKALP mRNA was detected in the granular layer, but not in the spinous or basal layers. In fully developed psoriatic lesions, elafin/SKALP mRNA was found in the suprabasallayers of the ridges, and in the upper two thirds of the stratum malpighii at the elongated rete ridges. Intense staining was noted near the subcorneal microabscess in psoriasis vulgaris and under the subcorneal pustule in localized pustular psoriasis. In the marginal psoriatic H uman leukocyte elastase (HLE) is a serine proteinase contained in azurophilic granules of polymorphonuclear leukocytes (PMNs) [1, 2] . At the site of inflammation, the enzyme is released with other proteinases, proteinase 3, cathepsin G, and collagenase, and causes severe tissue injury [1] [2] [3] . The degradation products of various matrix components act as chemoattractants and further recruit a greater number ofPMNs [4] . The HLE activity is, like other proteinases, regulated by endogenous specific inhibitors [1, 5] . Recently, a novel inhibitor for HLE, named elafin (elastase specific inhibitor) [6] , SKALP (skin-derived antileukoproteinase) [7, 8] , and ESI (elastase-specific inhibitor) [9] , has been found independently, from psoriatic epidermis, psoriatic scales, and sputum of patients with chronic bronchitis, respectively. Elafin/SKALP, also has potent inhibitory activity against proteinase 3, but not against cathepsin G [10] . The eDNA and genomic DNA for elafin/SKALP have been cloned and the deduced amino acid sequence indicated a 9.9-kDa mature protein with a unique structure of four repeats of putative transglutaminase substrate motifs as well as a proteinase inhibitor domain [11, 12] .
The expression of mRNA for elafin/SKALP, an inhibitor of leukocyte elastase and proteinase 3, in human normal and psoriatic epidermis was examined by in situ hybridization. In normal epidermis, elafin/SKALP mRNA was detected in the granular layer, but not in the spinous or basal layers. In fully developed psoriatic lesions, elafin/SKALP mRNA was found in the suprabasallayers of the ridges, and in the upper two thirds of the stratum malpighii at the elongated rete ridges. Intense staining was noted near the subcorneal microabscess in psoriasis vulgaris and under the subcorneal pustule in localized pustular psoriasis. In the marginal psoriatic H uman leukocyte elastase (HLE) is a serine proteinase contained in azurophilic granules of polymorphonuclear leukocytes (PMNs) [1, 2] . At the site of inflammation, the enzyme is released with other proteinases, proteinase 3, cathepsin G, and collagenase, and causes severe tissue injury [1] [2] [3] . The degradation products of various matrix components act as chemoattractants and further recruit a greater number ofPMNs [4] . The HLE activity is, like other proteinases, regulated by endogenous specific inhibitors [1, 5] . Recently, a novel inhibitor for HLE, named elafin (elastase specific inhibitor) [6] , SKALP (skin-derived antileukoproteinase) [7, 8] , and ESI (elastase-specific inhibitor) [9] , has been found independently, from psoriatic epidermis, psoriatic scales, and sputum of patients with chronic bronchitis, respectively. Elafin/SKALP, also has potent inhibitory activity against proteinase 3, but not against cathepsin G [10] . The eDNA and genomic DNA for elafin/SKALP have been cloned and the deduced amino acid sequence indicated a 9.9-kDa mature protein with a unique structure of four repeats of putative transglutaminase substrate motifs as well as a proteinase inhibitor domain [11, 12] .
PMNs are the predominant cells infiltrating in psoriatic microabscesses and spongiform pustules. In the lesional skin of psoriasis, the activity ofHLE is increased and is a sensitive marker for infiltration of neutrophils into skin [13, 14] . In addition, a large amount of elafin/SKALP activity is detected in the psoriatic lesional epidermis as well as cultured keratinocytes [7, 8] , and elafin/SKALP is localized in the suprabasal layers of lesional psoriatic epidermis [15] . Hence, the induction of elafin/SKALP gene expression by HLE is Manuscript received June 7, 1993 ; accepted for publication March 14, 1993 .
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epidermis, elafin/SKALP mRNA was expressed from the middle or upper spinous layer to the subcorneallayer, and the cells expressing elafin/SKALP mRNA increased especially under the parakeratotic corneal layer intermingled with pyknotic nuclei of neutrophils. These findings suggest that the induction of elafin/SKALP gene expression is related closely to the infiltration of neutrophils into the epidermis in psoriasis and plays an important role in protecting the skin components against the tissue damage caused by the infiltrated leukocytes. Key words: proteinase inhibitor/leukocyte elastase/in situ hybridization.] Invest DermatoI103: 88 -91, 1994 suggested to playa crucial role in the pathophysiology of psoriatic lesions.
In this study, we examined the localization of elafin/SKALP mRNA in normal and psoriatic epidermis by ill situ hybridization. We show the expression of the gene in normal epidermis and its dysregulation in psoriatic lesions.
MATERIALS AND METHODS
Materials Normal skin specimens were obtained from patients undergoing plastic surgery. Biopsies were taken from typical plaques of patients suffering from psoriasis vulgaris (n = 5), from non-Iesional skin of psoriatic patients, from the palmar lesion oflocalized pustular psoriasis, and from the lesional skin of patients suffering from atopic dermatitis. They had not received any treatment for at least 2 weeks prior to sampling. Half of the specimen was snap frozen in OCT compound (Miles Laboratories, U .S.A.) using liquid nitrogen, and the other half was fixed in formalin and paraffin embedded for routine hematoxylin-eosin staining. Frozen sections (5 -6 J.l1ll thick) were made to adhere to glass slides coated with Vectabond (Vector Laboratories Inc., U.S.A.) and were rapidly air dried. The sections were fixed in phosphate-buffered saline (PBS) containing 4% (w Iv) paraformaldehyde for 15 min at room temperature, air-dried, and stored at -70'C until use.
Construction of Plasm ids and Synthesis of RNA Probes The 0.3-kb second exon of the human elafin/SKALP gene (nucleotides; 1184 -1457) [12] was inserted into pDluescript II (Stratagene) and pGEM3Z (Promega Biotec) to construct pBSheg1.4r1 and PGEM-heg, respectively. The pBSheg1.4r1 plasmid or pGEM-heg plasmid was linearized with BcoRI to synthesize the antisense cRNAs or the control sense cRNAs for elafinJ SKALP mRNA by T3 or SP6 RNA polymerase, respectively, using a DIG RNA Labeling Kit (Boehringer Mannheim) as described p(eviously [16] . The full-length transcription of the probes was confirmed by Northern hybridization. The eRN As were fragmented by limited alkaline hydrolysis [17) and used for ill situ hybridization.
In $itu Hybridization III situ hybridization was performed as described previously (16) . The sections were rehydrated in PBS containing 0.3% (w Jv) 50% formamide containing 2 X SSC (1 X SSC: 15 mM NaCl, 15 mM sodium citrate) for 1 h. The sections hybridized in a mixture consisting of 20 mM Tris-HCl (pH 8.0), 2.5 mM ethylenediaminetetraacetic acid (EDTA), 50% formamide, 0.3 M NaCl, 1 X D enhardt's solution (Sigma), 1 mg/ml yeast tRNA (Sigma), 10% PEG6000, and 0.2 ng/)ll probe. After overnight incubation at 45°C, they were washed for 1 h at 45°C in 50% formamide and 2 X SSC, digested with 10 )lg/ml RNase (Sigma) in 0.5 M NaCI and 10 mM Tris-HCl (pH 8.0) for 30 min at 37"C. Hybridiza tion signals were detected using a Nucleic Acid Detection Kit (Boehringer Mannheim). Negative control sections hybridized with a sense probe were also examined.
RESULTS
Figure la, c, alld d shows the normal skin specimens of healthy individuals hybridized with elafin/SKALP antisense cRNA probe. In the normal epidermis from the face, elafin/SKALP mRNA was detected in the sub corneal layer, but not in the spinous or basal layers. In the perifollicular epidermis, subcorneal mRNA expression was increased (Fig la) . III the normal epidermis fro m the arm, mRNA positive cells were found ill the subcorneal monolayer fo- i) Localization of elafin/SKALP mRNA in lesional skin of atopic dermatitis. One or three subcorneallayers were stai ned.j) H ematoxylin-eosin staining of the fie ld corresponding to (i). Scale bar, 100 )lm.
cally (Fig Ie) . In the normal epidermis of the sole, elafin/SKALP mRNA was expressed in two to three subcorneallayers (Fig Id) , which were identified as granular layers by hematoxylin-eosin staining.
We next examined the distribution of elafin/SKALP mRNA in psoriatic epidermis. In non-Iesional epidermis of psoriatic patients, elafin/SKALP mRNA expression was seen in the subcorneal monolayer focally (Fig 2a) . Figure 2b shows a transitional zone from uninvolved to involved psoriatic epidermis hybridized with the elafin/SKALP antisense cRNA probe. The involved psoriatic epidermis expressed m?re abundant ela~n/SKA~P ~RN.A tha~ the uninvolved epidermis. In the margmal psonatlc epldenms, mRNA expression was found from the middle or upper spinous to the sub corneal layer. Under the parakeratotic corneal layer intermingled with pyknotic nuclei of PMNs, the cells expressing elafin/ SKALP mRNA increased markedly (Fig 2b,e,d) . In fully developed psoriatic lesions, hybridization was seen in the suprabasallayers of the ridges (Fig 2e) , and in the. upper ~o thirds of the stratum malpighii at the elongated rete ndges (Fig 2f) . Near the sub corneal microabscess, maximal staining was observed (Fig 2g) . Similarly, in palmar lesions o~localize.d pustular psoriasis, elafin/SKALP mRNA was distributed m the spmous layers under the subcorneal pustules (Fig 2h) . In chronic dermatitis with acanthosis of the epidermis (Fig  2j) elafin/SKALP mRNA expression was found in the one to three subcorneallayers (Fig 2i) that roughly corresponded to the granular layers. Neither the acanthotic spinous layer nor the basal layer was stained.
DISCUSSION
A recent immunohistochemical study using antiserum against purified elafin/SKALP has shown that the elastase inhibitor is present in many epidermal cel.ls of lesional skin of psoriasis [15] . This I~caliza tion is consistent With that of elafin/SKALP mRNA determmed by in situ hybridization. In psoriatic lesions, proteolysis of keratinocytes has been observed under .parakeratotic scales and .in the area surrounding the subcorneal microabscess [18] . Interestl11gly, cells expressing elafin/SKALP mR~A are increased with .downward e~ tension under the parakeratotic corneal layers contammg pyknotic nuclei ofPMNs. Moreover, strong signals of the mRNA are found around the subcorneal microabscess filled with PMNs. The pattern of the mRNA expression is similar to that of localized pustular psoriasis. !I~us, the up-regulation ?f elafi~/SKA~P gene expres~ion in psoriaSIS IS closely correlated With the I11filtratlon of PMNs mto the epidermis. Because the epidermis of chronic eczema shows acanthosis without PMN infiltration into the epidermis, elafin/ SKALP gene is expressed only in the thickened granular layer despite the presence of acanthosis. A factor, or the proteinases released from the infiltrating PMNs, may strongly induce the elafin/ SKALP gene expression in keratinocytes in psoriasis.
Previous studies have shown that no elafin/SKALP is produced in normal epidermis [7] . Immunohistochemical staining also could detect the proteinase inhibitor neither in normal epidermis nor in non-lesional epidermis of psoriasis [15] . However, in situ hybridization revealed that elafin/SKALP mRNA is synthesized in the granular layer of both normal and non-lesional epidermis. The localization of elafin/SKALP gene expression corresponds with that of trans glutaminase 1 (keratinocyte trans glutaminase), a cross-linking enzyme to form the cornified envelope [16, 19] . The substrates of the enzyme, such as involucrin, loricrin, and cystatin-lX, are also expressed in the granular layer [20 -22] . In addition, elafin/SKALP is cross-linked by transglutaminases [11] . These findings suggest that elafin/SKALP is a constituent protein of the cornified envelope. The reason for the discrepancy in the expression of the mRN A ELAFIN/SKALP GENE EXPRESSION IN EPIDERMIS 91 and protein of elafin/SKALP remains unknown. The translation of elafin/SKALP may be highly suppressed by a post-transcriptional mechanism in normal and uninvolved psoriatic epidermis.
In the development of psoriatic lesions, the gene expression of elafin/SKALP, which has been limited to the granular layer, becomes up-regulated, probably as a result of infiltration ofPMN into the epidermis. Keratinocytes may thus protect themselves and other skin components against the tissue damage caused by PMNs, resulting in the formation of a subcorneal microabscess.
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